Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05601817 · ClinicalTrials.gov registry record · NA
Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure
A NA study of Heart Failure and Mild Cognitive Impairment, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 172
- Enrollment target
- 1
- Study location
NCT05601817: Active NA study of Heart Failure and Mild Cognitive Impairment, sponsored by Indiana University.
NCT05601817 is a NA study of Heart Failure and Mild Cognitive Impairment that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 172 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05601817, a NA study of Heart Failure and Mild Cognitive Impairment, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
- 1
- Study location
Study Summary
This research project is relevant to public health because both heart failure (HF) and mild cognitive impairment (e.g., trouble remembering and concentrating beyond normal aging) are highly prevalent among older adults in the United States. Despite advances in health care, there are no effective interventions for treating cognitive impairment in HF, which if left untreated, leads to suboptimal health, quality of life, and shorter survival. Therefore, the investigators propose to test the effect of a dual-component intervention comprised of a virtual reality-based cognitive restoration intervention and computerized cognitive training on cognitive function and overall health among 172 older adults with HF who experience mild cognitive impairment.
Primary Outcome
Trail Making and Number Span Test from National Alzheimer's Coordinating Center Neuropsychological battery (Uniform Data Set V3.0)
Conditions Studied
Interventions
- BEHAVIORAL Vita
- BEHAVIORAL Com
- BEHAVIORAL Vita+Com
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What the registry record for NCT05601817 still lists
NCT05601817 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which Vita is the first listed.
NCT05601817 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05601817 about?
NCT05601817 is a clinical study titled "Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure". This research project is relevant to public health because both heart failure (HF) and mild cognitive impairment (e.g., trouble remembering and concentrating beyond normal aging) are highly prevalent among older adults in the United States. Despite advances in health care, there are no effective int...
What is the current status of trial NCT05601817?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2023-04-03. Estimated completion is 2027-03-31.
What conditions does trial NCT05601817 study?
This clinical trial studies the following conditions: Heart Failure, Mild Cognitive Impairment.
What interventions are being tested in trial NCT05601817?
The interventions under investigation include: Vita (BEHAVIORAL), Com (BEHAVIORAL), Vita+Com (BEHAVIORAL).
Who is sponsoring clinical trial NCT05601817?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05601817 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05601817's enrollment target sits among peer trials
172 179th of 397 higher than 218 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI